选择性内镜中GLP-1受体激动剂的周边程序安全性:一个多中心回顾性队列研究
Harsimran Kalsi1,2, Raghav Bassi3, Hussein Noureldine1,2
1Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, FL 32827, USA.
Journal of clinical medicine
|September 13, 2025
概括
类似葡萄糖-1受体激动剂 (GLP-1RA) 在选择性内镜中不会增加周围手术并发症. 这项研究没有发现吸血风险增加,GLP-1RA使用者显示氧气需求较少,住院时间较短.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 临床药理学 临床药理学
背景情况:
- 已知类似葡萄糖-1受体激动剂 (GLP-1 RAs) 可以延迟胃排空.
- 这种影响引发了人们对选择性内镜手术的周围手术安全性的担忧.
研究的目的:
- 评估在进行内镜检查的患者的手术前GLP-1RA使用和手术后并发症之间的关联.
- 特别调查吸入性肺炎和其他不良事件的风险.
主要方法:
- 成年患者进行门诊食道胃二透镜或结肠镜的回顾性队列研究.
- 患者被分为GLP-1RA使用者 (n=953) 或非使用者 (n=3289).
- 结果包括吸气,氧气需求,低血压,住院,ICU入院,住院时间和死亡率,以混因素和麻醉类型进行调整.
主要成果:
- 在这两组中都没有观察到任何愿望事件.
- GLP-1 RA使用与术后氧气需求和死亡率明显降低,住院时间缩短有关.
- 低血压和ICU入院率相似;然而,在监控麻醉护理/中度镇静 (MAC/MS) 下的GLP-1RA使用者与全身麻醉 (GA) 相比,住院几率更高.
结论:
- 在选择性内镜中,手术前GLP-1RA治疗与手术前并发症的增加无关.
- 虽然GLP-1 RA使用者的MAC/MS麻醉显示出更高的住院率,但其他显著的不良结果没有增加.
- 需要进一步的前性研究来阐明这种患者群体中麻醉选择的影响.
相关概念视频
Glucagon-like Receptor Agonists
850
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
850
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
574
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
574
Endoscopic Procedures I: Esophagogastroduodenoscopy
935
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
During an EGD, the endoscope can be used to:
935
Endoscopic Procedures V: ERCP
2.8K
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
2.8K
Dipeptidyl Peptidase 4 Inhibitors
596
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
596
Endoscopic Procedures III: Video Capsule Endoscopy
731
Capsule endoscopy, or wireless or video capsule endoscopy, is a diagnostic procedure for examining the entire gastrointestinal tract. Patients swallow a capsule about the size of a vitamin tablet. The capsule is equipped with a transmitter, a battery, an LED light source, and a color video camera to capture images throughout the gastrointestinal tract. This procedure is particularly useful for diagnosing conditions such as Crohn's disease, ulcerative colitis, tumors, polyps, ulcers,...
731

